ViiV Healthcare’s Tivicay PD Wins FDA Approval for Kids
LONDON, Aug 26, 2026 The U.S. Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) from ViiV Healthcare...
pediatric medicine
Advertisement
Devonian Begins Pediatric Phase II/III Thykamine Trial
QUÉBEC, Canada, July 21, 2026 Devonian Health Group has received Health Canada authorization to initiate a Phase II/III clinical...
Kyowa Kirin Wins EC Approval for Crysvita in Infants
GALASHIELS & MARLOW, United Kingdom, July 21, 2026 Kyowa Kirin EMEA has announced that the European Commission (EC) has...
BioMarin FDA Accepts VOXZOGO sNDA for Full Approval
SAN RAFAEL, Calif., July 13, 2026 BioMarin Pharmaceutical Inc. has reached a significant regulatory milestone after the U.S. Food...
Octapharma USA Expands FDA Approval for wilate® in Children
PARAMUS, N.J. | July 8, 2026 Octapharma USA has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
AbbVie Secures FDA Approval for SKYRIZI in Pediatric Psoriatic Disease
NORTH CHICAGO, Ill., June 26, 2026 AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI®...
Chiesi Wins EU Approval for Pediatric LOJUXTA Use
PARMA, Italy, June 5, 2026 Chiesi Global Rare Diseases has announced a major regulatory milestone following the European Commission’s...
Foresee Pharmaceuticals Reports Positive CPP Phase 3 Data
TAIPEI, Taiwan, May 27, 2026 Foresee Pharmaceuticals has announced the successful completion of its Casppian Phase 3 clinical trial...
Novartis Coartem Baby Wins WHO Nod for Infant Malaria
BASEL, Switzerland, April 24, 2026 Novartis has achieved a major global health milestone as the World Health Organization (WHO)...
CMP Pharma Introduces Alcohol-Free Norliqva for Pediatrics
FARMVILLE, N.C., April 20, 2026 CMP Pharma, Inc. has announced the availability of a newly reformulated Norliqva® (amlodipine) oral...
Advertisement
